Molecular Partners Ag MOLN
NASDAQ MOLN
$4.18 -0.17 (-3.76%)
As of: Sep 10, 2026 · 9:51 AM EDT

Molecular Partners Ag (MOLN) Asset Utilization Ratio (2021 - 2026)

Molecular Partners Ag's (MOLN) quarterly Asset Utilization Ratio came in at 0.05 in Q2 2026, up 13.63% year-over-year from 0.05 in Q2 2025, and up 13.63% quarter-over-quarter from 0.05 in Q2 2025.

Analysis

Molecular Partners Ag (MOLN) Asset Utilization Ratio (2021 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Asset Utilization Ratio for 6 consecutive years, with 0.05 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 13.63% year-over-year to 0.05 in Q2 2026; TTM through Jun 2026 was 0.05, a 13.63% increase from a year earlier, with the FY2024 full-year figure at 0.03, down 10.34% from the prior year.
  • Asset Utilization Ratio was 0.05 for Q2 2026 at Molecular Partners Ag, up from 0.05 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.78 in Q3 2023 and troughed at 0.04 in Q4 2023.
  • A 5-year average of 0.26 and a median of 0.06 in 2022 frame the typical range for Asset Utilization Ratio.
  • The widest YoY moves for Asset Utilization Ratio: up 1209.21% in 2023, down 95.19% in 2023.
  • Over 5 years, Asset Utilization Ratio stood at 0.74 in 2022, then slumped by 95.19% to 0.04 in 2023, then grew by 15.88% to 0.04 in 2024, then gained by 16.87% to 0.05 in 2025, then grew by 13.63% to 0.05 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.05 (Q2 2026), 0.05 (Q2 2025), and 0.04 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 0.40
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 0.58
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 0.47
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 0.38
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 0.20
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 0.90
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 0.33
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 0.00
10 Molecular Partners Ag 156.54 Mn 156.54 Mn - 0.01
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.05
Jun 30, 2025 0.05
Dec 31, 2024 0.04
Sep 30, 2024 0.05
Jun 30, 2024 0.05
Mar 31, 2024 0.04
Dec 31, 2023 0.04
Sep 30, 2023 0.78
Jun 30, 2023 0.76
Mar 31, 2023 0.78
Dec 31, 2022 0.74
Sep 30, 2022 0.08
Jun 30, 2022 0.07
Mar 31, 2022 0.06
Dec 31, 2021 0.08